Therapies
The Science
About us
Investors
News

Hit enter to search or ESC to close

Alterity Therapeutics Investor Presentation

April 10, 2019 Kerry Rowe

Alterity Therapeutics Investor Presentation 10 April 2019

Post navigation

Alterity Therapeutics Launches to Asian Investors

Alterity Therapeutics presents at the American Academy of Neurology Annual Meeting

Related Posts

Abstract from Movement Disorders Conference

June 22, 2016

Prana Announces Successful A$7 million Capital Raising

July 17, 2013

Prana receives Orphan Designation for PBT434 for treatment of MSA

January 31, 2019

Recent Posts

Alterity Therapeutics to Present at the Janney Healthcare Conference in New York
XBRL 30 June 2019 filed with the SEC
Quarterly Cash Flow Report
Alterity Therapeutics Announces Successful Completion of Phase 1 Clinical Trial
Alterity Therapeutics’ Finance News Network Presentation

Recent Comments

Archives

Archives

Categories

ASX Announcements
Investor Announcement

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Therapies
The Science
About us
Investors
News
Contact us

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065